Avadel pharmaceuticals provides corporate update and reports first quarter 2022 financial results

Dublin, ireland, may 09, 2022 (globe newswire) -- avadel pharmaceuticals plc (nasdaq: avdl), a biopharmaceutical company focused on transforming medicines to transform lives, today provided a corporate update, and announced its financial results for the first quarter ended march 31, 2022.
AVDL Ratings Summary
AVDL Quant Ranking